This topic contains a solution. Click here to go to the answer

Author Question: Which of the following issues makes inferences of causation more risky in quasi-experimental ... (Read 50 times)

Bernana

  • Hero Member
  • *****
  • Posts: 530
Which of the following issues makes inferences of causation more risky in quasi-experimental designs?
 
  a. lack of treatment manipulations
  b. nonrandom assignment to treatment conditions
  c. unreliable outcome measurements
  d. the use of both human as well as nonhuman sampling units

Question 2

Mill's method of difference implies that X is a(n) __________ condition of Y.
 
  a. activating
  b. sufficient
  c. necessary
  d. adequate



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Dnite

  • Sr. Member
  • ****
  • Posts: 297
Answer to Question 1

b

Answer to Question 2

c




Bernana

  • Member
  • Posts: 530
Reply 2 on: Jun 20, 2018
Great answer, keep it coming :)


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The average adult has about 21 square feet of skin.

Did you know?

Ether was used widely for surgeries but became less popular because of its flammability and its tendency to cause vomiting. In England, it was quickly replaced by chloroform, but this agent caused many deaths and lost popularity.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

According to animal studies, the typical American diet is damaging to the liver and may result in allergies, low energy, digestive problems, and a lack of ability to detoxify harmful substances.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library